The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126774252 12677425 2 F 20111119 20160829 20160823 20160902 EXP PHHY2011CA106410 SANDOZ 49.05 YR F Y 0.00000 20160902 CN COUNTRY NOT SPECIFIED CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126774252 12677425 1 SS XOLAIR OMALIZUMAB 1 Subcutaneous 375 MG, BIW (EVERY 2 WEEKS) U 0 375 MG VIAL QOW
126774252 12677425 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
126774252 12677425 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
126774252 12677425 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0052A 0 VIAL
126774252 12677425 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0061D 0 VIAL
126774252 12677425 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0062 0 VIAL
126774252 12677425 7 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0065E 0 VIAL
126774252 12677425 8 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0066B 0 VIAL
126774252 12677425 9 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0001E 0 VIAL
126774252 12677425 10 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0066B 0 VIAL
126774252 12677425 11 SS XOLAIR OMALIZUMAB 1 Unknown UNK U S0001E / S0068D 0 VIAL
126774252 12677425 12 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
126774252 12677425 13 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
126774252 12677425 14 PS PREDNISONE. PREDNISONE 1 Unknown UNK 80336
126774252 12677425 15 SS PREDNISONE. PREDNISONE 1 80336
126774252 12677425 16 SS PREDNISONE. PREDNISONE 1 80336
126774252 12677425 17 SS PREDNISONE. PREDNISONE 1 80336
126774252 12677425 18 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Unknown UNK U 0
126774252 12677425 19 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Unknown UNK U 0
126774252 12677425 20 C SINGULAIR MONTELUKAST SODIUM 1 Unknown UNK U 0
126774252 12677425 21 C VENTOLIN ALBUTEROL SULFATE 1 Unknown UNK U 0
126774252 12677425 22 C ALVESCO CICLESONIDE 1 Unknown UNK U 0
126774252 12677425 23 C CORTISONE CORTISONEHYDROCORTISONE 1 Unknown 50 MG, UNK U 0 50 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126774252 12677425 1 Asthma
126774252 12677425 14 Pulmonary function test decreased
126774252 12677425 15 Lung infection
126774252 12677425 16 Dyspnoea
126774252 12677425 17 Productive cough
126774252 12677425 18 Product used for unknown indication
126774252 12677425 19 Product used for unknown indication
126774252 12677425 20 Product used for unknown indication
126774252 12677425 21 Product used for unknown indication
126774252 12677425 22 Product used for unknown indication
126774252 12677425 23 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126774252 12677425 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126774252 12677425 Blood pressure decreased
126774252 12677425 Contusion
126774252 12677425 Dizziness
126774252 12677425 Dry mouth
126774252 12677425 Dry throat
126774252 12677425 Dyspnoea
126774252 12677425 Emphysema
126774252 12677425 Fatigue
126774252 12677425 Forced expiratory volume decreased
126774252 12677425 Haemorrhage
126774252 12677425 Injection site pain
126774252 12677425 Insomnia
126774252 12677425 Laceration
126774252 12677425 Lung infection
126774252 12677425 Lung neoplasm malignant
126774252 12677425 Nasopharyngitis
126774252 12677425 Nausea
126774252 12677425 Paraesthesia
126774252 12677425 Petechiae
126774252 12677425 Pharyngitis
126774252 12677425 Pneumonia
126774252 12677425 Productive cough
126774252 12677425 Pruritus
126774252 12677425 Pruritus generalised
126774252 12677425 Pulmonary function test abnormal
126774252 12677425 Pulmonary function test decreased
126774252 12677425 Pulmonary mass
126774252 12677425 Rash erythematous
126774252 12677425 Skin lesion
126774252 12677425 Weight decreased
126774252 12677425 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126774252 12677425 1 20111118 0
126774252 12677425 2 20111229 0
126774252 12677425 3 20130114 0
126774252 12677425 4 20151027 0
126774252 12677425 5 20151208 0
126774252 12677425 6 20160315 0
126774252 12677425 7 20160412 0
126774252 12677425 8 20160426 0
126774252 12677425 9 20160511 0
126774252 12677425 10 20160622 0
126774252 12677425 11 20160719 0
126774252 12677425 12 20160801 0
126774252 12677425 13 20160817 0